PHILADELPHIA CHROMOSOME-NEGATIVE LYMPHOBLASTIC LEUKEMIA

Clinical trials for PHILADELPHIA CHROMOSOME-NEGATIVE LYMPHOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new PHILADELPHIA CHROMOSOME-NEGATIVE LYMPHOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME-NEGATIVE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for young adults battling leukemia: testing a powerful drug combo

Disease control Not yet recruiting

This study is testing a combination of chemotherapy and an immunotherapy drug (blinatumomab) to treat a type of blood cancer called acute lymphoblastic leukemia (ALL) in adolescents and young adults. The goal is to see if this specific treatment plan is safe and effective for thi…

Matched conditions: PHILADELPHIA CHROMOSOME-NEGATIVE LYMPHOBLASTIC LEUKEMIA

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

PHILADELPHIA CHROMOSOME-NEGATIVE LYMPHOBLASTIC LEUKEMIA

Get alerted when new PHILADELPHIA CHROMOSOME-NEGATIVE LYMPHOBLASTIC LEUKEMIA trials appear

New hope for young adults battling leukemia: testing a powerful drug combo